Key Insights

No notable highlights available yet

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 8 trials

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 0 completed with results

Key Signals

Unknown4

Recruiting3

Not Yet Recruiting1

Clinical Trials (8)

Showing 8 of 8 trials

The Impact of De-implementing Urine Dipsticks for Diagnosis of UTIs in Hospitals

Valvular Heart Disease in Women Registry

UK Islet Autoantibody Registry

Real World Study of Deep Venous Thrombosis. Analysis of Prospective Cases in University Hospitals of São Paulo

Registry of Chronic Subdural Hematoma

Opinions of Healthcare Providers About a European Neuromodulation Register

A Single Center Registry of Coronary OCT

TaIwan Network of Targeted Temperature ManagEment for CARDiac Arrest Registry (TIMECARD)

Showing all 8 trials